|Project Title||Antiepileptic Drug Use|
Wednesday, November 20, 2013
Modular program-based one-time assessment of the use of antiepileptic drugs (AEDs), including acetazolamide, carbamazepine, clobazam, clonazepam, diazepam, ethosuxamide, ezogabine, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, lorazepam, oxcarbazepine, phenobarbital, phenytoin, pregabalin, primidone, rufinamide, tiagabine, topiramate, valproic acid, vigabatrin, and zonisamide. Incident use was determined 1) with respect to an AED of interest, rather than all AEDs, and 2) with respect to all AEDs, rather than a specific AED of interest. Modular programs are adaptable standardized programs. Results were generated using Modular Program 2, version 3.1; click here for more information. Programs were executed in April 2011.
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to email@example.com.
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.
2004 - 2012
Mini-Sentinel Distributed Database (MSDD)
- Vaccines, Blood & Biologics
- Devices and Radiologic Health